• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VI 型成骨不全症与胱氨酸贮积症并存。

A co-occurrence of osteogenesis imperfecta type VI and cystinosis.

机构信息

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Am J Med Genet A. 2012 Jun;158A(6):1422-6. doi: 10.1002/ajmg.a.35319. Epub 2012 Apr 23.

DOI:10.1002/ajmg.a.35319
PMID:22528245
Abstract

Osteogenesis imperfecta type VI (OI type VI) is a rare autosomal recessive disorder caused by mutations in the SERPINF1 gene that encodes pigment epithelium-derived factor (PEDF). Cystinosis is an autosomal recessive lysosomal transport disorder caused by mutations in the CTNS gene. Both SERPINF1 and CTNS are located on chromosome 17p13.3. We describe an individual presenting with both OI type VI and cystinosis. The patient was diagnosed with cystinosis at the age of 11 months and OI type VI on bone biopsy at the age of 8 years. He has sustained over 30 fractures during his lifetime, and at the age of 19 years entered end-stage renal disease and subsequent renal transplant. An Affymetrix 6.0 array was used to look for areas of loss of heterozygosity on chromosome 17. Sequencing of the SERPINF1 and CTNS genes was performed, followed by quantitative PCR and Western blot of PEDF to characterize the identified mutation. A 6.58 Mb region of homozygosity was identified on the Affymetrix 6.0 array, encompassing both the SERPINF1 and CTNS genes. Sequencing of the genes identified homozygosity for a known pathogenic CTNS mutation and for a novel in-frame duplication in SERPINF1. Skin fibroblasts produced a markedly reduced amount of SERPINF1 transcript and PEDF protein. This patient has the concurrent phenotype of two rare recessive diseases, cystinosis and OI type VI. We identified for the first time an in-frame duplication in SERPINF1 that is responsible for the OI type VI phenotype in this patient.

摘要

成骨不全症 VI 型(OI 型 VI)是一种罕见的常染色体隐性遗传病,由 SERPINF1 基因的突变引起,该基因编码色素上皮衍生因子(PEDF)。胱氨酸贮积症是一种常染色体隐性溶酶体转运障碍,由 CTNS 基因的突变引起。SERPINF1 和 CTNS 均位于 17p13.3 染色体上。我们描述了一名同时患有 OI 型 VI 和胱氨酸贮积症的患者。该患者在 11 个月大时被诊断为胱氨酸贮积症,在 8 岁时通过骨活检诊断为 OI 型 VI。他一生中经历了 30 多次骨折,19 岁时进入终末期肾病并随后进行了肾移植。使用 Affymetrix 6.0 阵列寻找 17 号染色体上的杂合性丢失区域。对 SERPINF1 和 CTNS 基因进行测序,然后进行 PEDF 的定量 PCR 和 Western blot,以表征鉴定的突变。在 Affymetrix 6.0 阵列上发现了一个 6.58 Mb 的纯合区域,包含 SERPINF1 和 CTNS 基因。对基因的测序发现 CTNS 基因的一种已知致病性突变和 SERPINF1 中的一种新的框内重复均为纯合子。皮肤成纤维细胞产生的 SERPINF1 转录本和 PEDF 蛋白明显减少。该患者同时具有两种罕见的隐性疾病,胱氨酸贮积症和 OI 型 VI。我们首次在 SERPINF1 中发现了一个框内重复,该重复导致该患者的 OI 型 VI 表型。

相似文献

1
A co-occurrence of osteogenesis imperfecta type VI and cystinosis.VI 型成骨不全症与胱氨酸贮积症并存。
Am J Med Genet A. 2012 Jun;158A(6):1422-6. doi: 10.1002/ajmg.a.35319. Epub 2012 Apr 23.
2
Novel Mutations in SERPINF1 Result in Rare Osteogenesis Imperfecta Type VI.丝氨酸蛋白酶抑制剂F1(SERPINF1)的新突变导致罕见的VI型成骨不全症。
Calcif Tissue Int. 2017 Jan;100(1):55-66. doi: 10.1007/s00223-016-0201-z. Epub 2016 Oct 28.
3
The effect of SERPINF1 in-frame mutations in osteogenesis imperfecta type VI.丝氨酸蛋白酶抑制剂F1(SERPINF1)框内突变在VI型成骨不全症中的作用。
Bone. 2015 Jul;76:115-20. doi: 10.1016/j.bone.2015.04.008. Epub 2015 Apr 11.
4
Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta.外显子组测序鉴定出常染色体隐性遗传型骨不全症中人类丝氨酸蛋白酶抑制剂因子 1 的截断突变。
Am J Hum Genet. 2011 Mar 11;88(3):362-71. doi: 10.1016/j.ajhg.2011.01.015. Epub 2011 Feb 25.
5
Extremely low level of serum pigment epithelium-derived factor is a special biomarker of Chinese osteogenesis imperfecta patients with SERPINF1 mutations.血清色素上皮衍生因子极低水平是中国成骨不全症 SERPINF1 突变患者的特殊生物标志物。
Clin Chim Acta. 2018 Mar;478:216-221. doi: 10.1016/j.cca.2017.10.032. Epub 2017 Nov 6.
6
Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice.恢复丝氨酸蛋白酶抑制剂F1(SERPINF1)的血清水平并不能纠正丝氨酸蛋白酶抑制剂F1基因敲除小鼠的骨骼表型。
Mol Genet Metab. 2016 Mar;117(3):378-82. doi: 10.1016/j.ymgme.2015.11.015. Epub 2015 Dec 2.
7
Novel mutations of the SERPINF1 and FKBP10 genes in Chinese families with autosomal recessive osteogenesis imperfecta.中国常染色体隐性遗传性骨发育不全家系中 SERPINF1 和 FKBP10 基因的新突变。
Int J Mol Med. 2018 Jun;41(6):3662-3670. doi: 10.3892/ijmm.2018.3542. Epub 2018 Mar 7.
8
Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI.循环色素上皮衍生因子缺乏是成骨不全症 VI 型的标志物。
J Clin Endocrinol Metab. 2012 Aug;97(8):E1550-6. doi: 10.1210/jc.2012-1827. Epub 2012 Jun 5.
9
Mutations in SERPINF1 cause osteogenesis imperfecta type VI.SERPINF1 基因突变导致Ⅵ型成骨不全症。
J Bone Miner Res. 2011 Dec;26(12):2798-803. doi: 10.1002/jbmr.487.
10
Osteogenesis Imperfecta Type VI in Individuals from Northern Canada.加拿大北部人群中的VI型成骨不全症。
Calcif Tissue Int. 2016 Jun;98(6):566-72. doi: 10.1007/s00223-016-0110-1. Epub 2016 Jan 27.

引用本文的文献

1
Clinical spectrum of rare bone fragility disorders and response to bisphosphonate treatment: a retrospective study.罕见骨脆弱症的临床表现谱及双磷酸盐治疗反应:一项回顾性研究。
Eur J Hum Genet. 2024 Dec;32(12):1559-1566. doi: 10.1038/s41431-024-01645-4. Epub 2024 Jun 26.
2
gene variants causing late-onset progressive deforming osteogenesis imperfecta - A study of 18 patients from India.导致迟发性进行性变形性成骨不全的基因变异——对18名印度患者的研究
Bone Rep. 2023 May 26;18:101690. doi: 10.1016/j.bonr.2023.101690. eCollection 2023 Jun.
3
Genetic variants and altered expression of SERPINF1 confer disease susceptibility in patients with otosclerosis.
丝氨酸蛋白酶抑制剂因子 1 的遗传变异和表达改变使耳硬化症患者易患病。
J Hum Genet. 2023 Sep;68(9):635-642. doi: 10.1038/s10038-023-01158-w. Epub 2023 May 18.
4
Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.遗传性胱氨酸病相关骨病:不只是肾性骨营养不良。
Int J Mol Sci. 2020 Apr 28;21(9):3109. doi: 10.3390/ijms21093109.
5
Whole-Exome Sequencing Identifies an Intronic Cryptic Splice Site in Causing Osteogenesis Imperfecta Type VI.全外显子组测序鉴定出导致VI型成骨不全症的一个内含子隐蔽剪接位点。
JBMR Plus. 2018 Apr 16;2(4):235-239. doi: 10.1002/jbm4.10044. eCollection 2018 Jul.
6
Skeletal implications and management of cystinosis: three case reports and literature review.胱氨酸病的骨骼影响及管理:三例病例报告及文献综述
Bonekey Rep. 2016 Aug 17;5:828. doi: 10.1038/bonekey.2016.55. eCollection 2016.
7
Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.色素上皮衍生因子恢复通过Wnt3a阻断增加VI型成骨不全模型中的骨量并改善骨可塑性。
FASEB J. 2016 Aug;30(8):2837-48. doi: 10.1096/fj.201500027R. Epub 2016 Apr 28.
8
Contemporary Approaches for Identifying Rare Bone Disease Causing Genes.鉴定罕见骨病致病基因的当代方法
Bone Res. 2013;1(4):301-310. doi: 10.4248/BR201304001.
9
Novel Deletion of SERPINF1 Causes Autosomal Recessive Osteogenesis Imperfecta Type VI in Two Brazilian Families.SERPINF1基因的新型缺失导致两个巴西家庭患常染色体隐性VI型成骨不全症。
Mol Syndromol. 2014 Dec;5(6):268-75. doi: 10.1159/000369108. Epub 2014 Nov 25.
10
A mouse model for human osteogenesis imperfecta type VI.一种人类成骨不全症 VI 型的小鼠模型。
J Bone Miner Res. 2013 Jul;28(7):1531-6. doi: 10.1002/jbmr.1892.